| Sample | Title | Value | Rank |
|---|
| GSM780707 | Untreated after 4 days (C1_1) | 53.423 | 57 |
| GSM780708 | Untreated after 4 days (C2_1) | 42.5872 | 16 |
| GSM780709 | Untreated after 4 days (C3_1) | 51.8592 | 54 |
| GSM780719 | Untreated after 4 days (C1_2) | 40.1301 | 7 |
| GSM780720 | Untreated after 4 days (C2_2) | 50.1667 | 49 |
| GSM780721 | Untreated after 4 days (C3_2) | 50.2269 | 49 |
| GSM780710 | Trastuzumab treated after 4 days (T1_1) | 56.9219 | 62 |
| GSM780711 | Trastuzumab treated after 4 days (T2_1) | 43.5565 | 20 |
| GSM780712 | Trastuzumab treated after 4 days (T3_1) | 55.6421 | 60 |
| GSM780722 | Trastuzumab treated after 4 days (T1_2) | 47.0413 | 37 |
| GSM780723 | Trastuzumab treated after 4 days (T2_2) | 43.9041 | 22 |
| GSM780724 | Trastuzumab treated after 4 days (T3_2) | 43.1679 | 18 |
| GSM780713 | Pertuzumab treated after 4 days (P1_1) | 42.1409 | 14 |
| GSM780714 | Pertuzumab treated after 4 days (P2_1) | 57.3191 | 62 |
| GSM780715 | Pertuzumab treated after 4 days (P3_1) | 44.5818 | 25 |
| GSM780725 | Pertuzumab treated after 4 days (P1_2) | 47.5609 | 39 |
| GSM780726 | Pertuzumab treated after 4 days (P2_2) | 42.8809 | 17 |
| GSM780727 | Pertuzumab treated after 4 days (P3_2) | 47.0065 | 37 |
| GSM780716 | Trastuzumab and Pertuzumab treated after 4 days (TP1_1) | 43.817 | 21 |
| GSM780717 | Trastuzumab and Pertuzumab treated after 4 days (TP2_1) | 44.1844 | 23 |
| GSM780718 | Trastuzumab and Pertuzumab treated after 4 days (TP3_1) | 47.3197 | 38 |
| GSM780728 | Trastuzumab and Pertuzumab treated after 4 days (TP1_2) | 44.0411 | 22 |
| GSM780729 | Trastuzumab and Pertuzumab treated after 4 days (TP2_2) | 40.8265 | 9 |